Transcriptional regulation by hypoxia inducible factors VL Dengler, MD Galbraith, JM Espinosa Critical reviews in biochemistry and molecular biology 49 (1), 1-15, 2014 | 856 | 2014 |
Mechanisms of transcriptional regulation by p53 KD Sullivan, MD Galbraith, Z Andrysik, JM Espinosa Cell Death & Differentiation 25 (1), 133-143, 2018 | 443 | 2018 |
HIF1A Employs CDK8-Mediator to Stimulate RNAPII Elongation in Response to Hypoxia MD Galbraith, MA Allen, CL Bensard, X Wang, MK Schwinn, B Qin, ... Cell 153 (6), 1327-1339, 2013 | 371 | 2013 |
Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms MA Allen, Z Andrysik, VL Dengler, HS Mellert, A Guarnieri, JA Freeman, ... Elife 3, e02200, 2014 | 266 | 2014 |
Trisomy 21 consistently activates the interferon response KD Sullivan, HC Lewis, AA Hill, A Pandey, LP Jackson, JM Cabral, ... eLife 5, e16220, 2016 | 262 | 2016 |
CDK8: a positive regulator of transcription MD Galbraith, AJ Donner, JM Espinosa Transcription 1 (1), 4-12, 2010 | 260 | 2010 |
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity Z Andrysik, MD Galbraith, AL Guarnieri, S Zaccara, KD Sullivan, A Pandey, ... Genome research 27 (10), 1645-1657, 2017 | 142 | 2017 |
Mitogen-induced recruitment of ERK and MSK to SRE promoter complexes by ternary complex factor Elk-1 HM Zhang, L Li, N Papadopoulou, G Hodgson, E Evans, M Galbraith, ... Nucleic acids research 36 (8), 2594-2607, 2008 | 105 | 2008 |
Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome KA Waugh, P Araya, A Pandey, KR Jordan, KP Smith, RE Granrath, ... Cell reports 29 (7), 1893-1908. e4, 2019 | 95 | 2019 |
The TIP60 Complex Is a Conserved Coactivator of HIF1A JI Perez-Perri, VL Dengler, KA Audetat, A Pandey, EA Bonner, M Urh, ... Cell Reports 16 (1), 37-47, 2016 | 91 | 2016 |
Therapeutic targeting of transcriptional cyclin-dependent kinases MD Galbraith, H Bender, JM Espinosa Transcription 10 (2), 118-136, 2019 | 87 | 2019 |
CDK8 Kinase Activity Promotes Glycolysis MD Galbraith, Z Andrysik, A Pandey, M Hoh, EA Bonner, AA Hill, ... Cell Reports 21 (6), 1495-1506, 2017 | 85 | 2017 |
Biochemical and genetic diversity of pectolytic enterobacteria causing soft rot disease of potatoes in New Zealand AR Pitman, PJ Wright, MD Galbraith, SA Harrow Australasian Plant Pathology 37, 559-568, 2008 | 82 | 2008 |
A kinase-independent role for cyclin-dependent kinase 19 in p53 response KA Audetat, MD Galbraith, AT Odell, T Lee, A Pandey, JM Espinosa, ... Molecular and cellular biology, 2017 | 78 | 2017 |
Specialized interferon action in COVID-19 MD Galbraith, KT Kinning, KD Sullivan, P Araya, KP Smith, RE Granrath, ... Proceedings of the National Academy of Sciences 119 (11), e2116730119, 2022 | 77 | 2022 |
Transcriptional Responses to IFN-γ Require Mediator Kinase-Dependent Pause Release and Mechanistically Distinct CDK8 and CDK19 Functions I Steinparzer, V Sedlyarov, JD Rubin, K Eislmayr, MD Galbraith, ... Molecular cell 76 (3), 485-499. e8, 2019 | 67 | 2019 |
Mutual exclusivity of MED12/MED12L, MED13/13L, and CDK8/19 paralogs revealed within the CDK-Mediator kinase module DL Daniels, M Ford, MK Schwinn, H Benink, MD Galbraith, ... J Proteomics Bioinform S 2 (2), 2013 | 66 | 2013 |
Seroconversion stages COVID19 into distinct pathophysiological states MD Galbraith, KT Kinning, KD Sullivan, R Baxter, P Araya, KR Jordan, ... Elife 10, e65508, 2021 | 50 | 2021 |
Multi-omics analysis reveals contextual tumor suppressive and oncogenic gene modules within the acute hypoxic response Z Andrysik, H Bender, MD Galbraith, JM Espinosa Nature Communications 12 (1), 1375, 2021 | 42 | 2021 |
ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas CG Abraham, MP Ludwig, Z Andrysik, A Pandey, M Joshi, MD Galbraith, ... Cell reports 24 (12), 3224-3236, 2018 | 42 | 2018 |